Checkpoint inhibitor treatment in patients with isolated in-transit melanoma metastases.

Volume: 38, Issue: 15_suppl, Pages: 10070 - 10070
Published: May 20, 2020
Abstract
10070 Background: In the context of multiple in-transit melanoma metastases without nodal involvement, a variety of treatment modalities have historically been employed including surgery, laser, isolated limb perfusion/infusion, intralesional interleukin-2, T-VEC and electrochemotherapy. Unfortunately, most patients treated with these modalities experience subsequent disease progression. While checkpoint inhibitors (CPI) are a standard of care...
Paper Details
Title
Checkpoint inhibitor treatment in patients with isolated in-transit melanoma metastases.
Published Date
May 20, 2020
Volume
38
Issue
15_suppl
Pages
10070 - 10070
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.